Home › Companies › Stoke Therapeutics, Inc.
How asset managers voted at Stoke Therapeutics, Inc.’s shareholder meetings, one page per proxy season, compiled from the votes funds and managers report on SEC Form N-PX and the company’s own results on Form 8-K.
| Season | Filed as | Ballot items | Asset managers |
|---|---|---|---|
| 2025-2026 | Stoke Therapeutics, Inc. | 5 | 225 |
| 2024-2025 | Stoke Therapeutics, Inc. | 6 | 135 |
Explore Stoke Therapeutics, Inc. in the interactive database
The seasons are grouped by the issuer number in the company’s CUSIP, not by its name. Ticker as listed by the SEC on October 19, 2026. This page is rebuilt weekly; built October 22, 2026.